top of page

PSA After Prostatectomy: Normal Levels, Rising PSA and What Happens Next

4 days ago
8 min read

Updated: 1 day ago

After a radical prostatectomy, PSA should become undetectable, usually below 0.1 ng/mL, within about 6 weeks. A PSA of 0.2 ng/mL or higher, confirmed on a second test, signals biochemical recurrence. Even then, the speed of the rise and your pathology report guide what happens next.


Medically reviewed by Assoc. Prof. Dr. Tuncay Taş, urologist. Updated November 2026.


For many men, the PSA result is the most stressful part of follow-up. This guide explains what each number means and when to test.


It also covers what doctors do if the PSA starts to rise. The advice suits readers in the US, Canada and the UK.


Why PSA should drop to almost zero


PSA, or prostate-specific antigen, is a protein made almost only by prostate cells. So once the surgeon removes the whole prostate, the main source of PSA is gone.


However, PSA does not vanish overnight. The PSA already in the blood halves every few days. Therefore, it takes several weeks to reach its lowest point, so the first test waits.


Meanwhile, modern tests are very sensitive. Many laboratories now report results down to 0.01 or 0.03 ng/mL. As a result, men sometimes see a tiny number where older tests showed "undetectable".


PSA levels after prostatectomy: what the numbers mean


The table shows how urologists usually read a PSA result after surgery. Still, a single number never tells the whole story. So the trend over time matters most.


PSA result (ng/mL)

What it usually means

Usual next step

Undetectable, below 0.01 to 0.03

The expected result after surgery

Routine follow-up tests

0.03 to 0.09, stable

Often benign tissue or test variation

Repeat in the same laboratory and watch the trend

0.1 to 0.19, or rising

Detectable PSA that needs closer watch

Repeat sooner and review the pathology report

0.1 or higher at the first test

PSA persistence: PSA never fell to zero

Review with the team, sometimes early imaging

0.2 or higher, confirmed

Biochemical recurrence

Doubling time, imaging and discussion of salvage radiotherapy


Units differ between countries, but the numbers match. In fact, 1 ng/mL equals 1 microgram per litre, the unit on many UK reports.


When to test PSA after surgery


The first test usually comes 4 to 8 weeks after surgery. In the UK, however, NICE advises waiting at least 6 weeks. After that, a regular schedule follows.


Time after surgery

Typical PSA schedule

4 to 8 weeks

First test, which should be undetectable

Year 1

Every 3 months with many teams

Year 2

Every 6 months; NICE advises at least every 6 months for 2 years

Year 3 onwards

At least once a year, usually for life


Use the same laboratory and the same test each time if you can. NICE also advises this, because different tests can give slightly different results. Then a small change is easier to judge.


For catheter, continence and return to work, see our guide to recovery after robotic prostatectomy.


Persistent PSA and rising PSA are not the same


Two patterns cause worry, and they mean different things. So it helps to know which one applies to you.


Persistent PSA


Here, PSA never falls to an undetectable level after surgery. For example, the first result may be 0.1 ng/mL or higher.


This can mean cancer cells outside the prostate bed. Less often, it comes from benign tissue left behind.


Therefore, persistent PSA usually leads to an early review. In addition, the team looks closely at the margins, lymph nodes and grade.


Rising PSA


In this pattern, PSA first falls to an undetectable level. Then, months or years later, it starts to climb. Once it reaches 0.2 ng/mL on two tests, doctors call it biochemical recurrence.


How common is it? The National Cancer Institute cites a large analysis of nearly 2,000 men. About 15 in 100 reached a PSA of 0.2 or higher over an average of 5.3 years.


What makes a PSA rise more likely


The pathology report from your operation predicts much of the risk. Therefore, keep a copy and bring it to every specialist visit.


  • Grade: a higher Gleason score or grade group means a higher chance of recurrence.

  • Stage: cancer that grew through the prostate capsule (pT3) raises the risk.

  • Margins: a positive margin means cancer cells reached the cut edge.

  • Seminal vesicles: spread into these glands increases the risk.

  • Lymph nodes: cancer in the removed nodes is the strongest warning sign.

  • PSA before surgery: a higher starting PSA also adds some risk.


Your urologist may also use a risk tool that combines these factors. For example, nomograms estimate the chance of a PSA rise over 5 or 10 years. However, such a figure is an average, so it never predicts one man’s course with certainty.


Clear margins and clean lymph nodes usually mean PSA checks alone. However, a positive margin or spread beyond the capsule may lead to added radiotherapy.


Dr. Taş makes this decision together with each man and his local team. Therefore, nobody rushes it.


Rising PSA: what happens next


A rising PSA is a signal, not a diagnosis of spread. In fact, NICE states that a rising PSA alone does not demand an immediate change in treatment. So a careful sequence of steps follows instead.


1. Confirm the result


First, your doctor repeats the test, ideally in the same laboratory. Indeed, a single high value can come from lab error. So no decision rests on one number.


2. Work out the PSA doubling time


Next, your urologist calculates how long the PSA takes to double. A doubling time of many months or years usually means slow disease. In contrast, a doubling time under 3 months suggests faster disease and needs quicker action.


For example, a PSA that climbs from 0.2 to 0.4 ng/mL over 12 months has a doubling time of about 12 months. In contrast, the same rise over 2 months is much faster. Therefore, it needs a prompt review.


3. Look for the source


Then imaging may follow. A PSMA PET-CT scan can find small areas of cancer even at low PSA levels. In contrast, standard bone scans usually help only when PSA is higher or symptoms appear.


4. Choose a treatment, or careful watching


The main treatment is salvage radiotherapy to the area where the prostate sat. NICE recommends offering it to men with biochemical recurrence and no known spread. It often works best when the PSA is still low, so timing matters.


Radiotherapy usually runs over several weeks of short daily sessions. Before you start, the oncologist explains possible effects on the bladder and bowel. Then you agree on a PSA schedule after treatment.


Hormone therapy is not routine after a PSA rise alone. Generally, NICE reserves it for spread, symptoms or a doubling time under 3 months. Meanwhile, some older men or men with slow rises choose watchful monitoring instead.


Indeed, a PSA rise often unfolds slowly. In the same data, the median time from PSA rise to visible spread was 8 years. So there is time for a calm, shared decision.


Low detectable PSA: benign causes


Not every detectable PSA means cancer. For instance, a tiny piece of benign prostate tissue can remain near the bladder neck. Such tissue generally gives a low, flat PSA that does not climb.


Ultrasensitive tests also pick up very small changes. A move from 0.02 to 0.03 ng/mL may simply be test variation. Therefore, your urologist judges the trend over several tests, not the last result alone.


Coping with PSA anxiety


Many men feel tense for days before each result. Doctors even have a name for it: "PSA anxiety". It is common, but it often eases as undetectable results add up.


A few habits can help. First, book the blood test and the result talk close together, so the wait stays short. Second, write down the number, the date and the laboratory each time.


Also, ask your doctor in advance what result would change the plan. Then a small reading such as 0.02 ng/mL feels less alarming. Finally, partners and support groups often help more than searching late at night.


Questions to ask at each PSA review


A short list keeps the appointment focused. For example, these questions cover the points that guide decisions:


  • Is my PSA undetectable on this test, and what is the lower limit of this laboratory?

  • Is the trend flat or rising compared with the last three results?

  • If it is rising, what is my PSA doubling time?

  • Does my pathology report change how closely we watch?

  • At what level would you suggest imaging or radiotherapy?

  • When is my next test, and who will act on the result?


PSA follow-up when you live far from your surgeon


Many men from the US, Canada and the UK have surgery abroad. Afterwards, they follow up at home. Then your family doctor, GP or local urologist can order every PSA test.


  • Keep one file: pathology report, operation note and every PSA result with dates.

  • Note the laboratory: stay with one laboratory where possible.

  • Agree a plan before you fly: know who acts if the PSA rises.

  • Share the pathology report: your local team needs it to judge the trend.


Dr. Taş gives every patient a discharge letter with the schedule and pathology results. As a result, the local team can follow the same plan without delay.


If you have not had treatment yet


Some readers are still choosing a treatment. Then it helps to know how PSA behaves after each option.


After surgery, PSA should fall to an undetectable level, which makes follow-up simple to read. For details of the operation, see the page on robotic prostatectomy.


In contrast, part of the prostate remains after radiotherapy or focal therapy. So PSA stays measurable, and different rules apply.


For selected small tumours, see the focal therapy page. Finally, if you still need a diagnosis, an MRI fusion prostate biopsy targets the suspicious area precisely.


When to see a urologist


See a urologist if your PSA never became undetectable, or if it rises on two tests. Also, ask for review if your pathology showed positive margins or spread beyond the capsule. Finally, new bone pain or urinary symptoms need prompt attention.


Assoc. Prof. Taş completed his uro-oncology fellowship at Heidelberg University. He has also published on uro-oncology training standards.


To plan a visit, book a consultation or message the team on WhatsApp. Bring your pathology report and all PSA results to the visit.


Frequently asked questions


What is a normal PSA after prostatectomy?


Once the prostate is gone, PSA should fall to an undetectable level. On most tests, that means below 0.1 ng/mL. On ultrasensitive tests, it is often below 0.03 ng/mL.


When is the first PSA test after prostatectomy?


The first test usually comes 4 to 8 weeks after surgery. In the UK, however, NICE advises no earlier than 6 weeks. So this gap gives the remaining PSA time to clear.


What PSA level means recurrence after prostatectomy?


Doctors usually call a PSA of 0.2 ng/mL or higher on two tests biochemical recurrence. However, it is a warning sign in the blood, not proof of spread.


Is a PSA of 0.05 after prostatectomy bad?


Not necessarily. Generally, a low, stable reading comes from benign tissue or test variation. So your urologist repeats the test and compares the trend in the same laboratory.


How fast does PSA rise if cancer comes back?


It varies widely, so doctors measure the PSA doubling time, which is how long PSA takes to double. A long doubling time usually means slow disease. In contrast, under 3 months suggests faster disease.


What is the treatment for rising PSA after prostatectomy?


The main option is salvage radiotherapy to the area where the prostate was. It often works best while the PSA is still low. Hormone therapy is not routine unless the disease has spread or PSA rises very fast.


How often do I need a PSA test after prostatectomy?


Many teams test every 3 months in year one and every 6 months in year two. NICE advises at least every 6 months for 2 years, then yearly. Then testing usually continues for life.


Sources



About the reviewer


Assoc. Prof. Dr. Tuncay Taş is a urologist in Istanbul with more than 20 years of experience and patients from over 60 countries. He graduated from Istanbul University in 2004, trained at Taksim Training and Research Hospital, completed a uro-oncology and laparoscopy fellowship at Heidelberg University and belongs to the EAU and the Endourological Society. Read his full profile.

 
 
 

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
Maria Hannachi, international patient representative at Safe Urology
bottom of page